EUVIMEDEUVIMED entdecken
Open Access

Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis

Katherine C Perez, Justin Alexander, Md Mostafizur Rahman, Haifa Alsharif, Yanping Liu, Jeong-A Kim, Chad S Hunter iD, Thanh Nguyen, Sushant Bhatnagar iD

Diabetes · 01.05.2026 · 75 (5) · 799-815

DOI: 10.2337/db25-0644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 20.04.2026. Verfasst von Katherine C Perez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, B…. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Insulin, Glucose, Nerve Tissue Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transition from a proliferative to a functionally mature state is a critical phase in postnatal pancreatic β-cell development, yet the molecular mechanisms coordinating this shift remain poorly understood. Here, we identify tomosyn-2 as a key regulator that restrains β-cell maturation and insulin secretory capacity. Tomosyn-2 expression progressively declines in mouse islets with age, coinciding with enhanced biphasic glucose-stimulated insulin secretion and reduced β-cell proliferation. Mice lacking tomosyn-2 exhibit improved glucose clearance, elevated plasma insulin levels, and enhanced insulin secretion from isolated islets without changes in insulin action. Mechanistically, tomosyn-2 interacts with syntaxin-1A to inhibit insulin granule exocytosis by limiting SNARE complex assembly. Transcriptomic and network analyses reveal that loss of tomosyn-2 is associated with coordinated changes in insulin secretion and cell-cycle regulation, reducing β-cell proliferation and mass expansion by downregulating Akt1 signaling and cell-cycle mediators, while promoting β-cell identity and functional maturation accompanied by altered islet cytoarchitecture. These findings identify tomosyn-2 as a molecular brake that balances proliferation and insulin secretion to achieve a threshold of functionally mature β-cell mass during postnatal development. Targeting tomosyn-2 or its downstream pathways may enhance β-cell functional competence and offer new strategies to restore insulin secretion in diabetes. Article Highlights The mechanisms governing the postnatal transition of pancreatic β-cells from a proliferative, immature state to a functionally mature, glucose-responsive state remain poorly understood. We investigate the role of tomosyn-2 in modulating β-cell proliferation and insulin secretion during postnatal maturation. Tomosyn-2 inhibits SNARE complex formation and insulin secretion, and its loss is associated with enhanced β-cell maturation, increased biphasic insulin secretion, reduced β-cell proliferation, and suppressed Akt1-cyclinD1 signaling. Tomosyn-2 functions as a physiological brake on insulin secretion, coordinating the balance between β-cell maturation and proliferation, with implications for diabetes pathogenesis and β-cell regenerative strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsInsulinGlucoseNerve Tissue ProteinsAnimalsInsulin SecretionMiceHomeostasisCell ProliferationSyntaxin 1Signal TransductionProto-Oncogene Proteins c-aktMice, Knockout

Substanzen

InsulinGlucoseSyntaxin 1Proto-Oncogene Proteins c-aktNerve Tissue Proteins

Autor:innen und Institutionen

  • Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Division of Endocrinology, Diabetes and Clinical Pharmacology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.
  • Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL.

ORCID-Profile: Chad S Hunter, Sushant Bhatnagar

Förderung

  • Division of Diabetes, Endocrinology, and Metabolic Diseases
  • NIDDK NIH HHS

Zitieren

APA

Perez, K. C., Alexander, J., Rahman, M. M., Alsharif, H., Liu, Y., Kim, J. A., Hunter, C. S., Nguyen, T., & Bhatnagar, S. (2026). Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis. Diabetes, 75(5), 799-815. https://doi.org/10.2337/db25-0644

Vancouver

Perez KC, Alexander J, Rahman MM, Alsharif H, Liu Y, Kim JA, et al. Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis. Diabetes. 2026;75(5):799-815. doi:10.2337/db25-0644

BibTeX
@article{Perez2026,
  author = {Perez, Katherine C and Alexander, Justin and Rahman, Md Mostafizur and Alsharif, Haifa and Liu, Yanping and Kim, Jeong-A and Hunter, Chad S and Nguyen, Thanh and Bhatnagar, Sushant},
  title = {Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {5},
  pages = {799--815},
  doi = {10.2337/db25-0644}
}
Kostenlos starten →